Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Activity of clarithromycin alone and in combination in a murine model of Mycobacterium kansasii infection.

Cynamon MH, Elliott SA, DeStefano MS, Yeo AE.

J Antimicrob Chemother. 2003 Aug;52(2):306-7. Epub 2003 Jul 1.

PMID:
12837729
2.

AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin.

Burman WJ, Stone BL, Brown BA, Wallace RJ Jr, Böttger EC.

Diagn Microbiol Infect Dis. 1998 Jun;31(2):369-71.

PMID:
9635911
3.

In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.

Guna R, Muñoz C, Domínguez V, García-García A, Gálvez J, de Julián-Ortiz JV, Borrás R.

J Antimicrob Chemother. 2005 Jun;55(6):950-3. Epub 2005 Apr 11.

PMID:
15824090
4.

[Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].

Kawata N, Kawahara S, Tada A, Takigawa N, Shibayama T, Soda R, Takahashi K.

Kekkaku. 2006 Apr;81(4):329-35. Japanese.

PMID:
16715941
5.

Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.

Griffith DE, Brown-Elliott BA, Wallace RJ Jr.

Clin Infect Dis. 2003 Nov 1;37(9):1178-82. Epub 2003 Oct 1.

PMID:
14557961
6.

Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.

Tompkins JC, Witzig RS.

Int J Tuberc Lung Dis. 2007 Mar;11(3):331-7.

PMID:
17352101
7.
8.

Treatment alternatives for Mycobacterium kansasii.

Graybill JR, Bocanegra R.

J Antimicrob Chemother. 2001 Apr;47(4):417-20.

PMID:
11266413
9.

Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice.

Lounis N, Truffot-Pernot C, Bentoucha A, Robert J, Ji B, Grosset J.

Antimicrob Agents Chemother. 2001 Nov;45(11):3229-30.

10.

Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model.

Furney SK, Skinner PS, Farrer J, Orme IM.

Antimicrob Agents Chemother. 1995 Mar;39(3):786-9.

11.

[Nontuberculous mycobacteriosis].

Nagai H.

Nihon Rinsho. 2003 Feb;61 Suppl 2:523-30. Review. Japanese. No abstract available.

PMID:
12722274
12.

Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.

da Silva Telles MA, Chimara E, Ferrazoli L, Riley LW.

J Med Microbiol. 2005 Oct;54(Pt 10):975-9.

PMID:
16157553
13.

Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin.

Marsollier L, Prévot G, Honoré N, Legras P, Manceau AL, Payan C, Kouakou H, Carbonnelle B.

Int J Antimicrob Agents. 2003 Dec;22(6):562-6.

PMID:
14659652
14.

Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.

Kyle SD, Porter WM.

Br J Dermatol. 2004 Nov;151(5):1101. No abstract available.

PMID:
15541095
15.

Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model.

Sun HK, Lee SY, Banevicius MA, Du X, Maglio D, Nicolau DP.

J Antimicrob Chemother. 2005 Sep;56(3):559-65. Epub 2005 Jul 15.

PMID:
16024590
16.

[Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].

Ibarrola M, Baraia-Etxaburu J, Sánchez R, Teira R, Unzaga J, Miguel Santamaría J.

Enferm Infecc Microbiol Clin. 2001 Feb;19(2):80-2. Spanish. No abstract available.

PMID:
11333577
17.

Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection.

Vallée E, Azoulay-Dupuis E, Swanson R, Bergogne-Bérézin E, Pocidalo JJ.

J Antimicrob Chemother. 1991 Feb;27 Suppl A:31-41.

PMID:
1827100
18.

Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice.

Klemens SP, Cynamon MH.

Antimicrob Agents Chemother. 1994 Jul;38(7):1455-9.

19.

Mycobacterium kansasii olecranon bursitis.

Barham GS, Hargreaves DG.

J Med Microbiol. 2006 Dec;55(Pt 12):1745-6.

PMID:
17108281
20.

Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.

Xiong JH, Ji B, Perani EG, Pétinon C, Grosset JH.

Int J Lepr Other Mycobact Dis. 1994 Mar;62(1):37-42.

PMID:
8189087

Supplemental Content

Support Center